Data from EMC - Curated by Toby Galbraith - Last updated 20 April 2017

Licensing authority

EMA (European Medicines Agency)

Indication(s)

ZEPATIER is indicated for the treatment of chronic hepatitis C (CHC) in adults.

Full Prescribing information

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Transplantation

See information on best practice in solid organ transplantation, and expert discussions on related hot topics.

Visit Transplantation

Chronic Obstructive Pulmonary Disease (COPD)

View highlights from recent congresses presented in new expert videos with leading physicians

Visit Chronic Obstructive Pulmonary Disease (COPD)

More information

Category Value
Agency product number EMEA/H/C/004126
Orphan designation No
Date First Approved 22-07-2016
Type Medicinal product subject to restricted medical prescription
Marketing authorisation holder Merck Sharp & Dohme Limited

Related Content